Breakthrough therapies for autoimmune diseases and cancer for patients with specific conditions.
abcuro.comNewton, Massachusetts
2 sources
Sources agree; no source states the company's headquarters.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Series C [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $200M | 2025-02-12 | New Enterprise Associates | No recent discussion |
2 sources [ VERIFIED · CORRECTED ] read against 2 sources Sources agree; no source states the company's headquarters. [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]2 pages read: abcuro.com, biospace.com·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]correctedchecked against 2 sources·[ BRANDING ]logo and colour from the homepage | ||||